DE69719367T2
(de)
|
1996-12-20 |
2003-10-16 |
Takeda Chemical Industries Ltd |
Verfahren zur herstellung einer zusammensetzung mit verzoegerter abgabe
|
US6191107B1
(en)
*
|
1997-09-26 |
2001-02-20 |
Takeda Chemical Industries, Ltd. |
Complex of human growth hormone and zinc
|
NZ525914A
(en)
|
1998-03-10 |
2004-03-26 |
Genentech Inc |
Novel polypeptides and nucleic acids encoding the same
|
EP3112468A1
(en)
|
1998-05-15 |
2017-01-04 |
Genentech, Inc. |
Il-17 homologous polypeptides and therapeutic uses thereof
|
DE69936382T3
(de)
|
1998-05-15 |
2011-07-07 |
Genentech, Inc., Calif. |
Therapeutische verwendungen von il-17 homologe polypeptide
|
US20020172678A1
(en)
|
2000-06-23 |
2002-11-21 |
Napoleone Ferrara |
EG-VEGF nucleic acids and polypeptides and methods of use
|
EP1978029A3
(en)
|
1999-06-15 |
2008-10-15 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids endoding the same
|
CA2492070A1
(en)
|
1999-12-01 |
2001-06-07 |
Kevin P. Baker |
Lung tumor marker pro4329 polypeptides and nucleic acids encoding the same
|
DK1897944T3
(da)
|
1999-12-23 |
2011-10-24 |
Genentech Inc |
IL-17 homologe polypeptider og terapeutisk anvendelse deraf
|
DK1246917T3
(da)
|
2000-01-13 |
2009-06-08 |
Genentech Inc |
Humane Stra6-polypeptider
|
KR20090007504A
(ko)
|
2000-02-24 |
2009-01-16 |
몬산토 테크놀로지 엘엘씨 |
소마토트로핀의 지속적인 방출을 위한 비수성 주사제제들
|
US6740520B2
(en)
|
2000-03-21 |
2004-05-25 |
Genentech, Inc. |
Cytokine receptor and nucleic acids encoding the same
|
JP2003528149A
(ja)
|
2000-03-24 |
2003-09-24 |
ジェネンテック・インコーポレーテッド |
軟骨性疾患の治療のためのインスリンの使用
|
AU6531101A
(en)
|
2000-06-02 |
2001-12-17 |
Genentech Inc |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
WO2002000261A2
(en)
|
2000-06-26 |
2002-01-03 |
Monsanto Technology Llc |
Surfactant-containing formulations for extended release of somatotropin
|
US6664234B1
(en)
|
2000-06-30 |
2003-12-16 |
Monsanto Technology Llc |
Non-aqueous injectable formulation preparation with pH adjusted for extended release of somatotropin
|
JP2004515467A
(ja)
|
2000-08-07 |
2004-05-27 |
ネクター セラピューティックス |
吸入可能な、噴霧乾燥した、最少の凝集物を有する4−ヘリックスバンドルタンパク質粉末
|
EP2014298A3
(en)
|
2000-08-24 |
2009-10-07 |
Genentech, Inc. |
Interleukin-22 polypeptides, nucleic acids encoding the same and methods for the treatment of pancreatic disorders
|
EP1944317A3
(en)
|
2000-09-01 |
2008-09-17 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
US6673580B2
(en)
|
2000-10-27 |
2004-01-06 |
Genentech, Inc. |
Identification and modification of immunodominant epitopes in polypeptides
|
US20070160576A1
(en)
|
2001-06-05 |
2007-07-12 |
Genentech, Inc. |
IL-17A/F heterologous polypeptides and therapeutic uses thereof
|
ATE431406T1
(de)
|
2002-02-25 |
2009-05-15 |
Genentech Inc |
Neuer typ-1-cytokinrezeptor glm-r
|
JP4869064B2
(ja)
|
2003-04-04 |
2012-02-01 |
ジェネンテック, インコーポレイテッド |
高濃度抗体及びタンパク質製剤
|
PL1636593T3
(pl)
|
2003-06-06 |
2009-08-31 |
Genentech Inc |
Modulowanie oddziaływania pomiędzy łańcuchem beta HGF i c-met.
|
SI2784084T2
(sl)
|
2003-07-08 |
2024-02-29 |
Novartis Pharma Ag |
Antagonistična protitelesa proti IL-17 A/F heterolognim polipeptidom
|
AU2004298483A1
(en)
|
2003-12-11 |
2005-06-30 |
Genentech, Inc. |
Methods and compositions for inhibiting c-met dimerization and activation
|
US7481997B1
(en)
|
2004-02-12 |
2009-01-27 |
Montana State University |
Snow mountain virus genome sequence, virus-like particles and methods of use
|
EP2289911A3
(en)
|
2004-03-30 |
2011-03-30 |
NsGene A/S |
Therapeutic use of a growth factor, NsG33
|
CN101947310A
(zh)
|
2004-10-27 |
2011-01-19 |
丹佛大学 |
促肾上腺皮质激素类似物以及相关方法
|
WO2006132788A2
(en)
|
2005-06-06 |
2006-12-14 |
Genentech, Inc. |
Transgenic models for different genes and their use for gene characterization
|
WO2008018854A2
(en)
|
2005-06-06 |
2008-02-14 |
The Rockefeller University |
Bactiophage lysins for bacillus anthracis
|
ES2827247T3
(es)
|
2005-06-21 |
2021-05-20 |
Xoma Us Llc |
Anticuerpos y fragmentos de los mismos que se unen a IL-1beta
|
US7582291B2
(en)
|
2005-06-30 |
2009-09-01 |
The Rockefeller University |
Bacteriophage lysins for Enterococcus faecalis, Enterococcus faecium and other bacteria
|
ZA200800970B
(en)
|
2005-08-15 |
2009-10-28 |
Genentech Inc |
Gene disruptions, compositions and methods relating thereto
|
ATE491026T1
(de)
|
2005-08-24 |
2010-12-15 |
Univ Rockefeller |
Ply-gbs-lysinmutanten
|
ZA200804162B
(en)
|
2005-11-21 |
2009-12-30 |
Genentech Inc |
Novel gene disruptions, compositions and methods relating thereto
|
US20080032343A1
(en)
|
2005-12-22 |
2008-02-07 |
Genentech, Inc. |
Recombinant Production of Heparin Binding Proteins
|
AR059300A1
(es)
|
2006-02-02 |
2008-03-26 |
Trimeris Inc |
Peptidos inhibidores de la fusion de vih con propiedades biologicas mejoradas
|
EP2050335A1
(en)
|
2006-02-17 |
2009-04-22 |
Genentech, Inc. |
Gene disruptions, compositions and methods relating thereto
|
EP2389946A1
(en)
|
2006-03-23 |
2011-11-30 |
Novartis AG |
Anti-tumor cell antigen antibody therapeutics
|
AU2007238186B2
(en)
|
2006-04-10 |
2014-01-09 |
Genentech, Inc. |
Disheveled PDZ modulators
|
JP2009536022A
(ja)
|
2006-04-19 |
2009-10-08 |
ジェネンテック・インコーポレーテッド |
新規の遺伝子破壊、それに関連する組成物および方法
|
CN101505789A
(zh)
*
|
2006-07-06 |
2009-08-12 |
株式会社大熊 |
稳定的人生长激素液体制剂
|
EP3124045A3
(en)
|
2006-12-20 |
2017-05-03 |
Xoma (Us) Llc |
Treatment of il-1 beta related diseases
|
CN101361968B
(zh)
|
2007-08-06 |
2011-08-03 |
健能隆医药技术(上海)有限公司 |
白介素-22在治疗脂肪肝中的应用
|
SI2391650T1
(sl)
|
2007-12-20 |
2015-03-31 |
Xoma (Us) Llc |
Postopki za zdravljenje protina
|
HUE049023T2
(hu)
|
2008-08-15 |
2020-08-28 |
Ironwood Pharmaceuticals Inc |
Linaklotidot tartalmazó, szájon át történõ beadásra szolgáló készítmények
|
US20120009225A1
(en)
*
|
2008-09-04 |
2012-01-12 |
Ironwood Pharmaceuticals, Inc. |
Stable Solid Formulation of Therapeutic Polypeptides Suitable for Oral Administration
|
WO2011017502A2
(en)
*
|
2009-08-06 |
2011-02-10 |
Ironwood Pharmaceuticals, Inc. |
Linaclotide-containing formulations for oral administration
|
CN102656266B
(zh)
|
2009-10-15 |
2016-08-03 |
霍夫曼-拉罗奇有限公司 |
具有改变的受体特异性的嵌合成纤维细胞生长因子
|
US8771693B2
(en)
|
2009-10-27 |
2014-07-08 |
Beth Israel Deaconess Medical Center, Inc. |
Methods and compositions for the generation and use of conformation-specific antibodies
|
NZ600363A
(en)
|
2009-12-21 |
2014-07-25 |
Ambrx Inc |
Modified porcine somatotropin polypeptides and their uses
|
CN102753573A
(zh)
|
2009-12-21 |
2012-10-24 |
Ambrx公司 |
经过修饰的牛促生长素多肽和其用途
|
CA2787208C
(en)
|
2010-01-15 |
2017-06-06 |
University Of Medicine And Dentistry Of New Jersey |
Use of vanadium compounds to accelerate bone healing
|
UA108636C2
(xx)
|
2010-02-17 |
2015-05-25 |
|
Пептид
|
SI2550018T1
(sl)
|
2010-03-22 |
2019-05-31 |
F. Hoffmann-La Roche Ag |
Sestavki in metode, uporabni za stabilizacijo formulacij, ki vsebujejo beljakovine
|
MX2012012743A
(es)
|
2010-05-03 |
2012-11-23 |
Genentech Inc |
Composiciones y metodos utiles para reducir la viscosidad de formulaciones que contienen proteina.
|
ES2880802T3
(es)
|
2010-06-24 |
2021-11-25 |
Hoffmann La Roche |
Composiciones y procedimientos para estabilizar formulaciones que contienen proteínas
|
RS59978B1
(sr)
|
2010-08-11 |
2020-03-31 |
Ironwood Pharmaceuticals Inc |
Stabilne formulacije linaklotida
|
CN102380091A
(zh)
|
2010-08-31 |
2012-03-21 |
健能隆医药技术(上海)有限公司 |
白介素-22在治疗病毒性肝炎中的应用
|
KR101886029B1
(ko)
|
2010-10-01 |
2018-08-07 |
호바 세라퓨틱스 에이피에스 |
무해자극통증, 통각과민증, 자발통증 및 헛통증의 치료를 위한 메테오린의 용도
|
US9345765B2
(en)
|
2010-10-08 |
2016-05-24 |
Shanghai Kexin Biotech Co., Ltd. |
Diagnostic and therapeutic uses of moesin fragments
|
CA2814024C
(en)
|
2010-10-08 |
2017-05-09 |
Shanghai Kexin Biotech Co., Ltd. |
Moesin modulators and uses thereof
|
WO2012092539A2
(en)
|
2010-12-31 |
2012-07-05 |
Takeda Pharmaceutical Company Limited |
Antibodies to dll4 and uses thereof
|
US10487114B2
(en)
|
2011-04-27 |
2019-11-26 |
Beth Israel Deaconess Medical Center, Inc. |
Methods for administering peptides for the generation of effective c/s conformation-specific antibodies to a human subject in need thereof
|
TWI586802B
(zh)
*
|
2011-06-02 |
2017-06-11 |
巴克斯歐塔公司 |
重組成對鹼性胺基酸蛋白酶之調配物
|
DK2776055T3
(en)
|
2011-08-17 |
2017-03-06 |
Ironwood Pharmaceuticals Inc |
TREATMENTS FOR GASTROINTESTINAL DISORDERS
|
LT3091029T
(lt)
|
2011-10-31 |
2023-02-27 |
F. Hoffmann-La Roche Ag |
Anti-il13 antikūno kompozicijos
|
WO2013096516A1
(en)
|
2011-12-19 |
2013-06-27 |
Xoma Technology Ltd. |
Methods for treating acne
|
US20140050720A1
(en)
|
2012-01-09 |
2014-02-20 |
The Scripps Research Institute |
Ultralong complementarity determining regions and uses thereof
|
US20150011431A1
(en)
|
2012-01-09 |
2015-01-08 |
The Scripps Research Institute |
Humanized antibodies
|
US9688747B2
(en)
|
2013-03-15 |
2017-06-27 |
Beth Israel Deaconess Medical Center, Inc. |
Methods and compositions for the generation and use of conformation-specific antibodies
|
EP3022224A2
(en)
|
2013-07-18 |
2016-05-25 |
Fabrus, Inc. |
Antibodies with ultralong complementarity determining regions
|
WO2015010100A2
(en)
|
2013-07-18 |
2015-01-22 |
Fabrus, Inc. |
Humanized antibodies with ultralong complementarity determining regions
|
JP6822839B2
(ja)
|
2013-09-13 |
2021-01-27 |
ザ・スクリップス・リサーチ・インスティテュート |
修飾された治療剤、及びその組成物
|
WO2015057834A1
(en)
|
2013-10-15 |
2015-04-23 |
The California Institute For Biomedical Research |
Peptidic chimeric antigen receptor t cell switches and uses thereof
|
CA2926698C
(en)
|
2013-10-15 |
2021-06-22 |
The California Institute For Biomedical Research |
Chimeric antigen receptor t cell switches and uses thereof
|
CN104623639A
(zh)
|
2013-11-07 |
2015-05-20 |
健能隆医药技术(上海)有限公司 |
白介素22二聚体在制备治疗胰腺炎药物中的应用
|
CN104623637A
(zh)
|
2013-11-07 |
2015-05-20 |
健能隆医药技术(上海)有限公司 |
Il-22二聚体在制备静脉注射药物中的应用
|
KR102455171B1
(ko)
|
2013-12-18 |
2022-10-14 |
더 스크립스 리서치 인스티튜트 |
변형된 치료제, 스테이플드 펩티드 지질 접합체, 및 이의 조성물
|
NL2014230B1
(en)
|
2015-02-04 |
2016-10-12 |
Stichting Vu-Vumc |
Wound healing formulation.
|
MA41629A
(fr)
|
2015-03-04 |
2018-01-09 |
Center For Human Reproduction |
Compositions et méthodes d'utilisation de l'hormone anti-müllérienne pour le traitement de l'infertilité
|
US10800828B2
(en)
|
2015-03-26 |
2020-10-13 |
The Scripps Research Institute |
Switchable non-scFv chimeric receptors, switches, and methods of use thereof to treat cancer
|
US11091546B2
(en)
|
2015-04-15 |
2021-08-17 |
The Scripps Research Institute |
Optimized PNE-based chimeric receptor T cell switches and uses thereof
|
WO2016205488A1
(en)
|
2015-06-17 |
2016-12-22 |
The California Institute For Biomedical Research |
Modified therapeutic agents and compositions thereof
|
WO2017181143A1
(en)
|
2016-04-15 |
2017-10-19 |
Generon (Shanghai) Corporation, Ltd. |
Use of il-22 in treating necrotizing enterocolitis
|
CN110267982B
(zh)
|
2016-10-19 |
2024-02-23 |
斯克利普斯研究所 |
具有人源化靶向部分和/或经过优化的嵌合抗原受体相互作用结构域的嵌合抗原受体效应细胞开关以及其用途
|
CA3133652A1
(en)
|
2019-04-01 |
2020-10-08 |
Genentech, Inc. |
Compositions and methods for stabilizing protein-containing formulations
|
MX2022001732A
(es)
|
2019-08-12 |
2022-05-06 |
Purinomia Biotech Inc |
Metodos y composiciones para promover y potenciar la respuesta inmunitaria mediada por linfocitos t dirigida a la adcc de las celulas con expresion de cd39.
|
WO2021081440A2
(en)
|
2019-10-24 |
2021-04-29 |
Minotaur Therapeutics, Inc. |
Chimeric cytokine modified antibodies and methods of use thereof
|
JP2024517759A
(ja)
|
2021-04-28 |
2024-04-23 |
ミノトール セラピューティクス インコーポレイテッド |
ヒト化キメラウシ抗体および使用方法
|
CN117940149A
(zh)
|
2021-05-06 |
2024-04-26 |
霍巴治疗公司 |
化疗诱导的神经性疼痛的预防和治疗
|
WO2023104960A1
(en)
|
2021-12-10 |
2023-06-15 |
Hoba Therapeutics Aps |
Treatment of nociceptive pain
|